OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TMDX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

TransMedics Group (TMDX) Earnings Date & Reports

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

TMDX is expected to report earnings to fall 65.76% to 31 cents per share on November 11

TransMedics Group TMDX Stock Earnings Reports

Q3'25

Est.

$0.31

Q2'25

Beat

by $0.47

Q1'25

Beat

by $0.44

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.17

The last earnings report on July 30 showed earnings per share of 92 cents, beating the estimate of 44 cents. With 688.21K shares outstanding, the current market capitalization sits at 3.90B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

TMDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TMDX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TMDX showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of a proprietary system for preserving human organs for transplant

Industry MedicalNursingServices

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

200 Minuteman Road

Phone

+1 978 552-0900

Employees

584

Web

https://www.transmedics.com